verapamil has been researched along with catechin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| González, R; Pascual, C; Romay, C | 1 |
| Sadzuka, Y; Sonobe, T; Sugiyama, T | 1 |
| He, L; Xia, YZ; Yan, M; Zhang, LY; Zhao, C | 1 |
| Choi, DH; Choi, JS; Chung, JH | 1 |
| da Rocha, MB; dos Santos Estevam, C; Marçal, RM; Pizza, C; Sant'ana, AE; Souza, FV | 1 |
| Agarwal, M; Dash, RP; Ellendula, B; Nivsarkar, M | 1 |
7 other study(ies) available for verapamil and catechin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Drugs effects on superoxide generation and chemiluminescence response of human leukocytes.
Topics: Catechin; Dipyridamole; Ditiocarb; Humans; Hypoxanthine; Hypoxanthines; Leukocytes; Luminescent Measurements; Luminol; Opsonin Proteins; Saccharomyces cerevisiae; Superoxides; Verapamil; Xanthine Oxidase | 1991 |
Efficacies of tea components on doxorubicin induced antitumor activity and reversal of multidrug resistance.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Caffeine; Calcium Channel Blockers; Carcinoma, Ehrlich Tumor; Catechin; Doxorubicin; Drug Resistance, Multiple; Drug Screening Assays, Antitumor; Drug Synergism; Flavonoids; Glutamates; Intracellular Fluid; Leukemia P388; Male; Mice; Neoplasm Transplantation; Phytotherapy; Tea; Theobromine; Verapamil | 2000 |
Inhibition of P-glycoprotein function by procyanidine on blood-brain barrier.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biflavonoids; Blood-Brain Barrier; Catechin; Cells, Cultured; Endothelial Cells; Humans; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Pinus; Plant Extracts; Proanthocyanidins; Rats; Rhodamine 123; Verapamil | 2009 |
Effects of oral epigallocatechin gallate on the oral pharmacokinetics of verapamil in rats.
Topics: Administration, Oral; Animals; Antioxidants; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Calcium Channel Blockers; Catechin; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Male; Rats; Rats, Sprague-Dawley; Verapamil | 2009 |
Antispasmodic effect of 4'-methylepigallocatechin on guinea pig ileum.
Topics: Animals; Barium Compounds; Calcium Chloride; Carbachol; Catechin; Chlorides; Guinea Pigs; Histamine; Ileum; Maytenus; Muscle Contraction; Muscle, Smooth; Parasympatholytics; Plant Extracts; Potassium Chloride; Verapamil | 2012 |
Increased intestinal P-glycoprotein expression and activity with progression of diabetes and its modulation by epigallocatechin-3-gallate: Evidence from pharmacokinetic studies.
Topics: Animals; Atorvastatin; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Catechin; Diabetes Mellitus, Experimental; Disease Progression; Ileum; Intestinal Absorption; Male; Rats; Sodium-Potassium-Exchanging ATPase; Verapamil | 2015 |